NO940524L - - Google Patents
Info
- Publication number
- NO940524L NO940524L NO940524A NO940524A NO940524L NO 940524 L NO940524 L NO 940524L NO 940524 A NO940524 A NO 940524A NO 940524 A NO940524 A NO 940524A NO 940524 L NO940524 L NO 940524L
- Authority
- NO
- Norway
- Prior art keywords
- condensed
- bases
- inorganic
- compounds
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Oppfinnelsen angår kondenserte 5-leddede heterocykler med den generelle formel A-B , (D hvor A, B, Yj og Y2 og Xx til X4 er som definert i krav l, deres tautomerer, deres stereoisomerer, innbefattet deres blandinger, og deres salter, spesielt deres fysiologisk akseptable salter, med uorganiske eller organiske syrer eller baser, som oppviser verdifulle farmakologiske egenskaper, fortrinnsvis aggregasjonshemmende virkninger, legemidler som inneholder disse forbindelser samt fremgangsmåter for deres fremstilling.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4304650A DE4304650A1 (de) | 1993-02-16 | 1993-02-16 | Kondensierte 5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
Publications (2)
Publication Number | Publication Date |
---|---|
NO940524D0 NO940524D0 (no) | 1994-02-15 |
NO940524L true NO940524L (no) | 1994-08-17 |
Family
ID=6480585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO940524A NO940524D0 (no) | 1993-02-16 | 1994-02-15 | Kondenserte 5-leddete heterocykler, fremgangsmåte for deres fremstilling, og legemidler inneholdende disse forbindelser |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0611660A3 (no) |
JP (1) | JPH072839A (no) |
AU (1) | AU5513094A (no) |
CA (1) | CA2115737A1 (no) |
DE (1) | DE4304650A1 (no) |
FI (1) | FI940697A (no) |
IL (1) | IL108648A0 (no) |
NO (1) | NO940524D0 (no) |
NZ (1) | NZ250879A (no) |
ZA (1) | ZA941021B (no) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2751647B1 (fr) * | 1996-07-25 | 1998-09-11 | Synthelabo | Derives de benzimidazole, leurs preparations et leurs applications en therapeutique |
TR200001079T2 (tr) | 1997-10-20 | 2000-07-21 | F.Hoffmann-La Roche Ag | Bisiklik kinaz inhibitörleri. |
DK1379520T3 (da) | 2001-02-23 | 2006-08-21 | Merck & Co Inc | N-substituerede ikke-aryl-heterocykliske NMDA/NR2B-antagonister |
BR0214019A (pt) | 2001-11-09 | 2004-10-13 | Boehringer Ingelheim Phamaceut | Benzimidazóis úteis como inibidores de proteìna quinase |
US7138420B2 (en) | 2002-08-08 | 2006-11-21 | Boehringer Ingelheim Pharmaceuticals Inc. | Substituted benzimidazole compounds |
CN101413143B (zh) | 2002-12-19 | 2013-09-18 | 斯克里普斯研究学院 | 稳定甲状腺素运载蛋白和抑制甲状腺素运载蛋白错折叠的组合物和方法 |
US7741341B2 (en) | 2003-05-19 | 2010-06-22 | Sanofi-Aventis Deutschland Gmbh | Benzimidazole-derivatives as factor Xa inhibitors |
EP1479676A1 (en) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | Benzimidazole-derivatives as factor xa inhibitors |
WO2005012288A1 (en) | 2003-08-01 | 2005-02-10 | Genelabs Technologies, Inc | Bicyclic imidazol derivatives against flaviviridae |
JP2007538103A (ja) | 2004-05-20 | 2007-12-27 | ザ スクリップス リサーチ インスティテュート | トランスサイレチン安定化 |
CA2709772A1 (en) * | 2007-12-21 | 2009-07-09 | Endacea, Inc. | A1 adenosine receptor antagonists |
MX2014003043A (es) | 2011-09-16 | 2015-02-05 | Pfizer | Formas solidas de un inhibidor de disociacion transtiretina. |
WO2014125084A1 (en) | 2013-02-14 | 2014-08-21 | Technische Universität München | Hydroxyindalpine derivatives and their medical use |
WO2014151729A1 (en) | 2013-03-15 | 2014-09-25 | Irm Llc | Compounds and compositions for the treatment of parasitic diseases |
CA2899646C (en) | 2013-03-15 | 2021-08-31 | Hydra Biosciences, Inc. | Substituted xanthines and methods of use thereof |
US9296754B2 (en) | 2013-03-15 | 2016-03-29 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
US9233961B2 (en) | 2013-03-15 | 2016-01-12 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
HUE040254T2 (hu) | 2013-12-19 | 2019-02-28 | Novartis Ag | Protozoa proteaszóma inhibitor [1,2,4]triazolo[1,5-a]pirimidinszármazékok paraziták által okozott betegségek, például leishmaniasis kezelésére |
JP6403865B2 (ja) * | 2014-07-03 | 2018-10-10 | シャンハイ インスティテュート オブ ファーマシューティカル インダストリー | ダビガトランエテキシラート中間体の製造方法及び中間体化合物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2208367B (en) | 1987-07-09 | 1991-07-03 | Alcatel Business Systems | Franking machine |
US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
DE4124942A1 (de) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE4129603A1 (de) * | 1991-09-06 | 1993-03-11 | Thomae Gmbh Dr K | Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE4214245A1 (de) * | 1992-04-30 | 1993-11-04 | Thomae Gmbh Dr K | Tritiummarkierte fibrinogen-rezeptor-antagonisten, deren verwendung und verfahren zu ihrer herstellung |
ATE140225T1 (de) * | 1992-04-28 | 1996-07-15 | Thomae Gmbh Dr K | Tritiumarkierte fibrinogen-rezeptor-antagonisten, deren verwendung und verfahren zur ihrer herstellung |
-
1993
- 1993-02-16 DE DE4304650A patent/DE4304650A1/de not_active Withdrawn
-
1994
- 1994-02-14 EP EP9494102222A patent/EP0611660A3/de not_active Withdrawn
- 1994-02-14 JP JP6017568A patent/JPH072839A/ja active Pending
- 1994-02-15 NZ NZ250879A patent/NZ250879A/xx unknown
- 1994-02-15 AU AU55130/94A patent/AU5513094A/en not_active Abandoned
- 1994-02-15 NO NO940524A patent/NO940524D0/no unknown
- 1994-02-15 ZA ZA941021A patent/ZA941021B/xx unknown
- 1994-02-15 FI FI940697A patent/FI940697A/fi not_active Application Discontinuation
- 1994-02-15 IL IL10864894A patent/IL108648A0/xx unknown
- 1994-02-15 CA CA002115737A patent/CA2115737A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ZA941021B (en) | 1995-08-15 |
EP0611660A3 (de) | 1994-09-14 |
NZ250879A (en) | 1995-09-26 |
FI940697A (fi) | 1994-08-17 |
JPH072839A (ja) | 1995-01-06 |
IL108648A0 (en) | 1994-05-30 |
CA2115737A1 (en) | 1994-08-17 |
NO940524D0 (no) | 1994-02-15 |
DE4304650A1 (de) | 1994-08-18 |
AU5513094A (en) | 1994-08-18 |
EP0611660A2 (de) | 1994-08-24 |
FI940697A0 (fi) | 1994-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO940524L (no) | ||
NO922940L (no) | Fem-leddete heterocykliske forbindelser, fremgangsmaate for deres fremstilling og legemidler inneholdende dem | |
NO923466L (no) | Heterocykliske forbindelser med 5 ledd, fremgangsmaate forfremstilling, samt legemidler som inneholder disse forbindelser | |
NO933248L (no) | Cykliske urinstoffderivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling | |
NO934501L (no) | Karboksylsyrederivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling | |
NO940261L (no) | 5-leddete heterocykler, fremgangsmåte ved fremstilling derav og legemidler som inneholder disse forbindelser | |
DK0567966T3 (da) | Cykliske aminoderivater, fremgangsmåder til deres fremstilling og lægemidler indeholdende disse forbindelser | |
NO972881L (no) | Piperazinderivater, legemidler som inneholder disse, anvendelse derav og fremgangsmåte for deres fremstilling | |
NO941677L (no) | Tetrazolderivater av gallesyrer, fremgangsmåter for fremstilling og deres anvendelse som legemiddel | |
CA2054850A1 (en) | Cyclic imino derivatives, pharmaceutical compositions containing these compounds and processes for preparing them | |
NO941680D0 (no) | Monomere gallesyrederivater, fremgangsmåte for fremstilling av dem og deres anvendelse som legemiddel | |
NO932120L (no) | Bifenylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling | |
DK0951474T3 (da) | Nye cyclosporinderivater, deres fremstilling og farmaceutiske præparater deraf | |
EP0528369A3 (de) | Cyclische Iminoderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
NO941678L (no) | nor-gallesyrederivater, fremgangsmåte for fremstilling og anvendelse av dem som legemiddel | |
MX9803954A (es) | Derivados de aminoacidos, composiciones farmaceuticas que contienen estos compuestos y procesos para prepararlos. | |
NO930517L (no) | Benzimidazolylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling | |
DK0726899T3 (da) | Nye pyrazincarboxamidderivater, deres fremstilling og deres anvendelse i lægemidler | |
NO924921L (no) | Polyaspartamidderivater som adsorbsjonsmiddel for gallesyrer, polyaspartamidderivat lastet med gallesyrer og fremgangsmaater for fremstilling av disse, samt deres anvendelse som legemiddel | |
NO931527L (no) | Cykliske iminoderivater, medisinpreparater inneholdende disse, og fremgangsmaate for deres fremstilling | |
ES2140396T3 (es) | Compuesto de tienodiazepina y su uso. | |
KR890009389A (ko) | 바이러스를 억제시키는 방법 | |
NO301826B1 (no) | Heterotricyklisk substituerte fenylcykloheksankarboksylsyrederivater, legemidler inneholdende dem og deres anvendelse for fremstilling av legemidler | |
ATE169922T1 (de) | Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase | |
TR199701258T1 (xx) | S�bstit�e edilmi� amidinler, ila�lar ve bunlar�n �retilmesi. |